Future Pharmaceuticals Announces Inclinix’s Participation in an “Ask The Experts” Patient Recruitment Feature

New York, NY, October 03, 2006 --(PR.com)-- Tobin Geatz, Founder of Inclinix Inc, recently participated in an exclusive executive “Ask the Experts” feature, within Future Pharmaceuticals, in order to address a number of challenges faced by US Pharmaceuticals and Biotechnology companies regarding strategies and approaches to Patient Recruitment within Clinical Trials. This feature, allowed for Geatz to provide insight into Inclinix’s proven best practices and plans for future development.

Transcripts of the entire Q&A discussion will be featured within the Q3 Edition of Future Pharmaceuticals (FP) a high-level publication both online and in print, designed to provide senior-level business and technology executives with an in-depth analysis of, and key insight into market trends and innovative technologies.  The publication, which features editorials from leading industry analysts, business strategy experts, and solution providers, was released on August 7, 2006. 

“We are delighted with Inclinix’s participation within Future Pharmaceuticals,” said Alaina Cagliostro, Director, FP.  “With industry analysts, leading pharmaceutical and biotechnology executives reading this publication in order to properly align their Clinical Trials investments with their business strategy, Tobin Geatz will create tremendous mindshare regarding the value that Inclinixs’ leading solutions bring to the marketplace.”

Within the overall coverage on Clinical Trials, this edition of FP will feature editorial thought leadership from Rebecca Kush, Founder of CDISC, Kenneth Getz, Senior Research Fellow at the Tufts Center for the study of Drug Development, and Roni Thaler, President and CEO of CISCRP.  The complete digital version of the FP publication, including the Training and Learning panel discussion, can be found at Future Pharmaceuticals' website.

About FP:  Published by Analysts in Media, Inc., Future Pharmaceuticals has forged powerful relationships with key industry leaders to provide a platform for successful brand recognition, and for senior decision-makers to have the means to procure and plan implementation strategies based on the topics covered. Positioned to be an authoritative resource within top pharmaceutical companies as well as small, specialty, and biotech, Future Pharmaceuticals is geared to create a deep penetration into a highly targeted and responsive audience, bridging the gap between the industries' top issues and the solutions top-tier vendors can provide.

About Analysts In Media:
Analysts In Media, Inc. is a leading global provider of specialized information services for the professional and enthusiast markets, actively bringing buyers and sellers together across targeted media channels – publications, events, and online.

###